ABCG2 and colonic neoplasm: The inhibition of IRE1α RNase activity with the small-molecule 4μ8c suppresses the drug-induced expression of these ABC transporters and resensitizes 5-FU-resistant colon cancer cells to drug treatment (Gao et al., 2020).